- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Venetoclax – November 2017
Venetoclax: Tablet 10 mg, Tablet 50 mg, Tablet 100 mg; Venclexta®
Last updated
16 March 2018